Short-Course Regimens for DS-PTB in AIDS Patients
Starting soon · Not applicable
Conditions studied: Tuberculosis in HIV-infected Individuals, Drug Susceptible Pulmonary Tuberculosis
In brief
This study adopts a multicenter, open-label, randomized controlled design, conducted across key designated AIDS diagnosis and treatment hospitals nationwide. It aims to compare the efficacy and safety of the 2HPMZ/2HPM regimen versus the 2HRZE/4HR regimen in treating HIV-associated drug-susceptible pulmonary tuberculosis (DS-TB) among patients with a CD4+ T-cell count \< 100 cells/μL. A total of 148 participants will be enrolled and randomized 1:1 into two groups: 74 cases in the 2HPMZ/2HPM group and 74 cases in the 2HRZE/4HR group.
Key facts
- Study ID
- NCT07608172
- Run by
- Shanghai Public Health Clinical Center
- People needed
- 148
- Starts
- 2026-05-25
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2026-05-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years, able to understand and sign the informed consent form.
- Confirmed HIV infection.
- Baseline CD4+ T-lymphocyte count < 100 cells/μL.
- Confirmed active pulmonary tuberculosis.
- Agree to receive antituberculosis treatment and antiretroviral therapy during the study period.
You may not qualify if…
- Known or suspected resistance to any of the drugs in the regimen, including rifapentine, moxifloxacin, rifampicin, isoniazid, ethambutol, and pyrazinamide.
- Body weight < 40 kg.
- Received the current tuberculosis treatment for more than 7 days.
- Complicated with tuberculous meningitis or other severe forms of tuberculosis.
- Severe liver dysfunction (ALT or AST > 5 times the upper limit of normal, ULN). - - Severe renal dysfunction (eGFR < 30 mL/min/1.73m²).
- Baseline electrocardiogram (ECG) showing QTc interval > 500 ms.
- Pregnant or lactating women.
- Presence of other conditions deemed inappropriate for study participation by the investigators.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.